BPC-157 dosing reference
Common vial sizes, typical dose ranges, and a free reconstitution calculator pre-configured for BPC-157. Not medical advice. Always verify against your vial label and your provider's protocol.
BPC-157 reconstitution
Pre-loaded with common BPC-157 values — adjust to your vial.
Inputs
BPC-157 common vial sizes: 5 mg, 10 mg. Typical dose range: 0.2–0.5 mg. Research publications. Not medical advice.
for a 0.2 mg dose
- Concentration
- 2.50 mg/ml
- Volume
- 0.080 ml
- Per ml
- 100 u
Not medical advice. Always verify against your vial label and your provider's instructions. Re-check before drawing.
About BPC-157
Healing peptides are studied for tissue repair, gut integrity, and post-injury recovery. BPC-157 (a fragment of body protection compound) and TB-500 (thymosin β4) are the most-discussed in this category.
How it's used
Typically injected subcutaneously near (but not directly into) the area of injury, daily or several times per week, in cycles of 2–6 weeks. Some users prefer oral or intranasal delivery for gut-related goals.
Storage
Reconstituted vials kept refrigerated at 36–46°F (2–8°C). Most peptides are stable for 2–4 weeks reconstituted. Lyophilized (powdered) vials store much longer in a freezer.
Watch for
- Mild local irritation at injection site
- Fatigue or flu-like feeling in early days
- Headaches reported by a minority of users
- Limited long-term safety data — these compounds are not FDA-approved for human use
BPC-157 vs other Healing peptides
2 compounds comparedReference dose ranges for the healing category. Tap any compound to open its full reference page.
| Compound | Brand names | Typical dose | Vial sizes | Status |
|---|---|---|---|---|
| BPC-157 | — | 0.2–0.5 mg | 5, 10 mg | Research |
| TB-500 | Thymosin Beta-4® | 2–10 mg | 2, 5, 10 mg | Research |
Dose ranges summarized from FDA-approved labels (for approved compounds) and peer-reviewed research (for the rest). See the resources page for source databases.
BPC-157 FAQ
Answers, not hype.
BPC-157 is a peptide in the Healing category. It is a research peptide and is not FDA-approved for human use. The dose ranges shown (0.2–0.5 mg) are summarized from peer-reviewed research literature where evidence is preliminary.
BPC-157 most commonly ships in 5, 10 mg vials. Typical reconstitution volumes are 2, 3, 5 ml of bacteriostatic water — choose the volume to land on a syringe-friendly unit count for your target dose.
Use the formula concentration = vial mg ÷ BAC water ml, then volume = dose mg ÷ concentration, then units = volume × 100 (for U-100). For example, a 5 mg vial reconstituted with 2 ml gives 2.50 mg/ml — at the typical low dose of 0.2 mg that resolves to 8.0 units. The free reconstitution calculator on this site verifies the math against your specific vial.
No. BPC-157 is a research peptide and is not FDA-approved for human use in the United States as of April 2026. Any use must come through a licensed healthcare provider, typically via a compounding pharmacy.
Side-effect profiles for research peptides are characterized in published research rather than an FDA label. Most users report mild local reactions at the injection site, occasional fatigue, and headache in the first few doses. Long-term human safety data is limited for most research compounds. Discuss with your prescribing provider before starting.
No. The values shown are reference numbers summarized from authoritative sources — FDA-approved labels for approved compounds and peer-reviewed research for the rest. They are not personalized recommendations. Always follow your prescribing provider's instructions and verify every calculation against your vial label.
Other Healing peptides
References & sources
Research peptideBPC-157 is a research peptide. It is not FDA-approved for human use. The ranges shown above are summarized from peer-reviewed clinical and pre-clinical literature, where evidence remains preliminary. Discuss any use with a licensed healthcare provider.
- PubMed research literaturePeer-reviewed research on BPC-157. Evidence is preliminary; BPC-157 is not FDA-approved for human use.
- ClinicalTrials.govNIH database of registered clinical trials involving BPC-157, completed or in progress.
See the resources page for the full list of databases this site cross-checks against.
Track BPC-157 in the app
History, reminders, body-map injection rotation, Apple Watch logging, and a doctor-ready PDF — all bundled with the calculator.
Download on theApp Store